Gemcitabine plus platinum-based chemotherapy for first-line treatment of hepatocholangiocarcinoma: an AGEO French multicentre retrospective study

BACKGROUND: Hepatocholangiocarcinoma (cHCC-ICC) is a rare liver tumour for which no data on chemosensitivity exist. The aims of this multicentre study were to evaluate overall survival (OS), progression-free survival (PFS), and prognostic factors in cHCC-ICC treated by gemcitabine plus platinum as f...

Descripción completa

Detalles Bibliográficos
Autores principales: Salimon, Maëva, Prieux-Klotz, Caroline, Tougeron, David, Hautefeuille, Vincent, Caulet, Morgane, Gournay, Jérôme, Matysiak-Budnik, Tamara, Bennouna, Jaafar, Tiako Meyo, Manuela, Lecomte, Thierry, Zaanan, Aziz, Touchefeu, Yann
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2018
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5808029/
https://www.ncbi.nlm.nih.gov/pubmed/29169182
http://dx.doi.org/10.1038/bjc.2017.413

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5808029/
https://www.ncbi.nlm.nih.gov/pubmed/29169182
http://dx.doi.org/10.1038/bjc.2017.413

Ejemplares similares